Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BYHepatology communications

Five critical blind spots limiting translational progress in primary sclerosing cholangitis.

  • Martin Cornillet1
  1. 1Department of Medicine, Center for Infectious Medicine (CIM), ANA Futura, Karolinska Institutet Campus Flemingsberg, Huddinge, Sweden.
Read full textPDFDOICite

Related

  1. A Case of Pancreaticobiliary Maljunction Associated with IgG4-related Sclerosing Cholangitis and Type 1 Autoimmune Pancreatitis
    Tadashi Toyohara, Itaru Naitoh, Go Asano +10
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  2. Current Management of Primary Sclerosing Cholangitis (PSC) ~A Proposal for Early-stage PSC~
    Hiroyuki Isayama, Toshio Fujisawa, Taito Fukuma +11
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  3. Paradoxical hepcidin–iron dysregulation in primary sclerosing cholangitis
    Petr Kordac, Milan Hajek, Monika Cahova +7
    PLOS OnePeer-reviewedCC BY 4.0Full textGeneral biologyMedical imaging & radiologyPLOSPMC
  4. Case Report: Diffuse peribiliary metastasis from ovarian cancer mimicking sclerosing cholangitis without a detectable mass.
    Xiao Li, Zhijie Zhang
    Frontiers in oncologyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  5. Anti-integrin αvβ6 Autoantibodies in the Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
    K. Chikugo, T. Kuwada, M. Shiokawa +25
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv

Cite

BibTeXRIS
BibTeX
@article{cornillet2026five,
  title = {{Five critical blind spots limiting translational progress in primary sclerosing cholangitis.}},
  author = {Martin Cornillet},
  journal = {Hepatology communications},
  year = {2026},
  month = oct,
  doi = {10.1097/hc9.0000000000001072},
  url = {https://europepmc.org/article/MED/42900158},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Five critical blind spots limiting translational progress in primary sclerosing cholangitis.
AU  - Martin Cornillet
PY  - 2026
DA  - 2026/10/19
JO  - Hepatology communications
DO  - 10.1097/hc9.0000000000001072
UR  - https://europepmc.org/article/MED/42900158
SN  - 2471-254X
ER  -